BioSpace News Archive

Lysogene announced its participation to the upcoming 16th WORLDSymposium™ on Lysosomal Diseases to be held February 10 – 13, 2020 in Orlando, FL, USA.

Carbiotix announces that the company has launched its second generation diagnostic platform for gut health based on Next Generation Sequencing.

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology announced the signing of a license agreement granting Aelian access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to support Aelian’s commercial functional genomic screening platform.

The U.S. Food and Drug Administration (FDA) Priority Review for capmatinib is based on Phase 2 data in first-line and previously treated patients with MET exon 14 skipping (METex14) mutated advanced non-small cell lung cancer (NSCLC)

The Annual General Meeting on October 30 resolved to extend the company’s financial year to the following period, July 1, 2019 - December 31, 2020.

MEDICREA®, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD® ASI proprietary software platform, concierge expert services and technologies, announced that it has received FDA-Clearance for UNiD® IB3D Patient-Matched interbody cages which completes its UNiD® ASI platform technology.

Medivir AB invites investors, analysts and the media to an R&D Day in Stockholm, Monday March 2, 2020, at 14:00 to 16:30 CET.

Vakrangee announces alliance with vHealth by Aetna, a Digital Primary Healthcare service for rural India